Klotho: A new therapeutic target in diabetic retinopathy?

doi:10.4239/wjd.v14.i7.1027

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3206)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1692

Figures (1-1)

241

Tables (1-1)

203

Sum=2254

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

109

Download

318

Sum=427

Publishing Process of This Article

Item

Count

Browse

124

Download

246

Sum=370

Jul 15, 2023 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Jul 15, 2023; 14(7): 1027-1036
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1027

Open in New Tab Full Size Figure Download Figure

Figure 1 Positive effects of Klotho in diabetic retinopathy. VEGF-A: Vascular endothelial growth factor A.

Citation: Puddu A, Maggi DC. Klotho: A new therapeutic target in diabetic retinopathy? World J Diabetes 2023; 14(7): 1027-1036
URL: https://www.wjgnet.com/1948-9358/full/v14/i7/1027.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i7.1027